跳至主要内容
临床试验/CTRI/2018/01/011277
CTRI/2018/01/011277已完成未知

Efficacy of Nepafenac 0.1% versus Flurbiprofen 0.03% in maintaining intraoperative mydriasis during Phaco emulsification. A comparative study.

I0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Cataract patients 40 yrs age and above

排除标准

  • 1)Diabetes Mellitus and Hypertension
  • 2)Ocular co-morbidities like injury, uveitis and local pupillary abnormalities
  • 3)Any previous intraocular surgery
  • 4)Pseudo-exfoliation
  • 5)Eye with <6.00 mm pupil size at the baseline
  • 6)Intra-operative surgical complications such as posterior capsular tear,
  • vitreous loss, nucleus drop, zonular dehiscence
  • 7)Pregnant and nursing mothers.
  • 8)Knowledge or suspicion of allergy or hypersensitivity to preservatives, steroids, topical NSAIDS or any other component of study medications.
  • 9)Use of any eye medications except artificial tear drops 3 weeks prior to inclusion in the study.
  • 10)Use of alpha 1 receptor blocker (Tamsulosin) or tricyclic antidepressants (TCA) that may induce intra-operative miosis.
  • 11)Use of systemic NSAIDS or steroids within 4 weeks prior to inclusion in the study.

研究者

发起方
I

相似试验